Lourd Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | $607K | Buy |
13,374
+260
| +2% | +$11.8K | 0.06% | 54 |
|
2019
Q1 | $626K | Sell |
13,114
-20,015
| -60% | -$955K | 0.06% | 51 |
|
2018
Q4 | $1.72M | Sell |
33,129
-2,215
| -6% | -$115K | 0.13% | 34 |
|
2018
Q3 | $2.19M | Buy |
35,344
+509
| +1% | +$31.6K | 0.14% | 31 |
|
2018
Q2 | $1.93M | Sell |
34,835
-2,056
| -6% | -$114K | 0.27% | 31 |
|
2018
Q1 | $2.33M | Sell |
36,891
-68
| -0.2% | -$4.3K | 0.31% | 25 |
|
2017
Q4 | $2.27M | Buy |
36,959
+23,159
| +168% | +$1.42M | 0.15% | 31 |
|
2017
Q3 | $880K | Buy |
13,800
+131
| +1% | +$8.35K | 0.08% | 41 |
|
2017
Q2 | $762K | Sell |
13,669
-300
| -2% | -$16.7K | 0.07% | 40 |
|
2017
Q1 | $760K | Buy |
13,969
+1,735
| +14% | +$94.4K | 0.07% | 42 |
|
2016
Q4 | $715K | Buy |
12,234
+515
| +4% | +$30.1K | 0.07% | 39 |
|
2016
Q3 | $632K | Sell |
11,719
-595
| -5% | -$32.1K | 0.07% | 38 |
|
2016
Q2 | $906K | Buy |
12,314
+81
| +0.7% | +$5.96K | 0.26% | 36 |
|
2016
Q1 | $781K | Buy |
12,233
+773
| +7% | +$49.4K | 0.09% | 42 |
|
2015
Q4 | $788K | Buy |
11,460
+687
| +6% | +$47.2K | 0.08% | 46 |
|
2015
Q3 | $638K | Buy |
10,773
+162
| +2% | +$9.59K | 0.07% | 47 |
|
2015
Q2 | $706K | Buy |
10,611
+103
| +1% | +$6.85K | 0.07% | 50 |
|
2015
Q1 | $678K | Buy |
10,508
+87
| +0.8% | +$5.61K | 0.07% | 52 |
|
2014
Q4 | $615K | Buy |
10,421
+177
| +2% | +$10.4K | 0.06% | 54 |
|
2014
Q3 | $524K | Buy |
10,244
+195
| +2% | +$9.98K | 0.05% | 58 |
|
2014
Q2 | $487K | Buy |
10,049
+49
| +0.5% | +$2.38K | 0.05% | 63 |
|
2014
Q1 | $520K | Hold |
10,000
| – | – | 0.06% | 55 |
|
2013
Q4 | $532K | Hold |
10,000
| – | – | 0.06% | 57 |
|
2013
Q3 | $463K | Sell |
10,000
-811
| -8% | -$37.5K | 0.05% | 58 |
|
2013
Q2 | $483K | Buy |
+10,811
| New | +$483K | 0.06% | 55 |
|